Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus (Q42539361)

2 November 2017

title

Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus (English)

1 reference

2 November 2017

1 reference

Thompson KD

1

1 reference

2 November 2017

publication date

1 July 1998

1 reference

2 November 2017

1 reference

2 November 2017

volume

39

1 reference

2 November 2017

issue

1

1 reference

2 November 2017

page(s)

55-61

1 reference

Antiviral activity of African medicinal plants

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

New therapeutic approaches to the alphaherpesvirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Infections with herpes simplex viruses (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Infections with herpes simplex viruses (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Antiviral properties of the seed extract of an Indian medicinal plant, Pongamia pinnata, Linn., against herpes simplex viruses: in-vitro studies on Vero cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Herpes simplex virus type 2 in the United States, 1976 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Prior herpes simplex virus type 2 infection as a risk factor for HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Inhibition of herpes simplex virus type 1 by aqueous extracts from shoots of Helichrysum aureonitens (Asteraceae).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Antiviral activities of Nepalese medicinal plants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

Isolation of the anthropogenic compound fluoranthene in a screening of Chinese medicinal plants for antiviral compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2898%2900027-8

7 January 2021

10.1016/S0166-3542(98)00027-8

Identifiers

DOI

1 reference

2 November 2017

1 reference